Literature DB >> 23913799

Clinical presentation and early evolution of spastic ataxia of Charlevoix-Saguenay.

Antoine Duquette1, Bernard Brais, Jean-Pierre Bouchard, Jean Mathieu.   

Abstract

BACKGROUND: Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is an increasingly recognized form of spastic ataxia worldwide, but early diagnosis remains a challenge.
METHODS: We reviewed the initial presentation (n = 40) and early clinical evolution (n = 50) of a large ARSACS cohort that was followed at the Saguenay Neuromuscular clinic.
RESULTS: The average age at presentation was 3.41 ± 1.55 years. Increased deep tendon reflexes were more common than spasticity initially, and the neuropathy only became apparent clinically in the second decade. Despite a homogeneous genetic background, some patients showed no signs of neuropathy or spasticity by the age of 18 years.
CONCLUSIONS: At presentation, ARSACS lacks certain features that are considered typical in adults after years of evolution. Considering that ARSACS is probably under-diagnosed, it should be included in the differential diagnosis of early onset ataxias with or without pyramidal features and is worthwhile to consider in older patients, even when some features are absent.
© 2013 Movement Disorder Society.

Entities:  

Keywords:  ARSACS; French-Canadian; neuropathy; spasticity; spinocerebellar ataxia

Mesh:

Year:  2013        PMID: 23913799     DOI: 10.1002/mds.25604

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

1.  Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  Roxanne Larivière; Rébecca Gaudet; Benoit J Gentil; Martine Girard; Talita Cristiane Conte; Sandra Minotti; Kim Leclerc-Desaulniers; Kalle Gehring; R Anne McKinney; Eric A Shoubridge; Peter S McPherson; Heather D Durham; Bernard Brais
Journal:  Hum Mol Genet       Date:  2014-09-26       Impact factor: 6.150

Review 2.  A novel homozygous SACS mutation identified by whole exome sequencing-genotype phenotype correlations of all published cases.

Authors:  Georgia Xiromerisiou; Katerina Dadouli; Chrysoula Marogianni; Antonios Provatas; Panagiotis Ntellas; Dimitrios Rikos; Pantelis Stathis; Despina Georgouli; Gedeon Loules; Maria Zamanakou; Georgios M Hadjigeorgiou
Journal:  J Mol Neurosci       Date:  2019-11-07       Impact factor: 3.444

3.  Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)-First Report of Clinical and Imaging Features from India, and a Novel SACS Gene Duplication.

Authors:  Pankaj A Agarwal; Priti Ate-Upasani; Vedam L Ramprasad
Journal:  Mov Disord Clin Pract       Date:  2017-08-09

4.  SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy.

Authors:  Katharina Vill; Wolfgang Müller-Felber; Dieter Gläser; Marius Kuhn; Veronika Teusch; Herbert Schreiber; Joachim Weis; Jörg Klepper; Anja Schirmacher; Astrid Blaschek; Manuela Wiessner; Tim M Strom; Bianca Dräger; Kristina Hofmeister-Kiltz; Moritz Tacke; Lucia Gerstl; Peter Young; Rita Horvath; Jan Senderek
Journal:  Hum Genet       Date:  2018-11-21       Impact factor: 4.132

5.  An exploratory natural history of ataxia of Charlevoix-Saguenay: A 2-year follow-up.

Authors:  Cynthia Gagnon; Isabelle Lessard; Caroline Lavoie; Isabelle Côté; Raphaël St-Gelais; Jean Mathieu; Bernard Brais
Journal:  Neurology       Date:  2018-08-29       Impact factor: 9.910

6.  Cerebellum and neuropsychiatric disorders: insights from ARSACS.

Authors:  Andrea Mignarri; Alessandra Tessa; Maria Alessandra Carluccio; Alessandra Rufa; Eugenia Storti; Giovanni Bonelli; Christian Marcotulli; Filippo Maria Santorelli; Luca Leonardi; Carlo Casali; Antonio Federico; Maria Teresa Dotti
Journal:  Neurol Sci       Date:  2013-12-07       Impact factor: 3.307

7.  Novel Mutation in SACS Gene in a Patient with Autosomal Recessive Spastic Ataxia Charlevoix-Saguenay.

Authors:  Igor Petrov
Journal:  Mov Disord Clin Pract       Date:  2021-06-22

8.  Assessment of the impact of an exercise program on the physical and functional capacity in patients with autosomal recessive spastic ataxia of Charlevoix-Saguenay: An exploratory study.

Authors:  Olivier Audet; Hung Tien Bui; Maxime Allisse; Alain-Steve Comtois; Mario Leone
Journal:  Intractable Rare Dis Res       Date:  2018-08

Review 9.  Recessive cerebellar and afferent ataxias - clinical challenges and future directions.

Authors:  Marie Beaudin; Mario Manto; Jeremy D Schmahmann; Massimo Pandolfo; Nicolas Dupre
Journal:  Nat Rev Neurol       Date:  2022-03-24       Impact factor: 42.937

10.  Novel compound heterozygous mutation in SACS gene leads to a milder autosomal recessive spastic ataxia of Charlevoix-Saguenay, ARSACS, in a Finnish family.

Authors:  Johanna Palmio; Mikko Kärppä; Peter Baumann; Sini Penttilä; Jukka Moilanen; Bjarne Udd
Journal:  Clin Case Rep       Date:  2016-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.